TrialBMC cancer2022

Optimizing MATRix as remission induction in PCNSL: de-escalated induction treatment in newly diagnosed primary CNS lymphoma.

Julia Wendler et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.